COMP <GO>
AGX vs PG // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Argan Inc. (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: AGX 5
— PG 10
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: PG
LAST: $344.11 (-3.57%) • MKT CAP: $5.01B
options-implied-move
6.90%
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
options-implied-move
6.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AGX VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AGX | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.50% | 51.20% | -30.70 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.90% | 25.40% | -0.50 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 36.0x | 16.2x | +19.80 | PG | /valuation <GO> |
| Free Cash Flow Yield | 8.21% | 3.77% | +4.44 | AGX | /fcf-yield <GO> |
| Operating Margin | 14.30% | 24.30% | -10.00 | PG | /operating-margins <GO> |
| Net Profit Margin | 14.60% | 19.00% | -4.40 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 8.10% | 0.30% | +7.80 | AGX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.48% | 2.65% | -2.17 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.22 | 5.59 | +0.63 | AGX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | AGX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.90% | 6.50% | +0.40 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.1 | 62.7 | -22.57 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 0.87 | +0.13 | AGX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.8x | 21.7x | +12.10 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.01B | $372.21B | -$367.21B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AGX REV | PG REV | AGX GROSS % | PG GROSS % | AGX FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $944.6M | $84.28B | 20.5% | 51.2% | $410.8M | $14.04B |
| FY 2024 | $874.2M | $84.04B | 16.1% | 51.4% | $161.0M | $16.52B |
| FY 2023 | $573.3M | $82.01B | 44.0% | 44.0% | $91.1M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AGX // BETA 1.00
PG // BETA 0.87